Castleview Partners’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Sell
510
-2
-0.4% -$1.15K 0.11% 182
2026
Q1
$349K Sell
512
-1
-0.2% -$691 0.18% 127
2025
Q4
$293K Buy
+513
New +$298K 0.14% 143
2024
Q3
Sell
-3
Closed -$1.31K 782
2024
Q2
$1.31K Buy
+3
New +$1.37K ﹤0.01% 785
2022
Q2
Sell
-2,472
Closed -$1.1M 797
2022
Q1
$1.1M Sell
2,472
-981,072
-100% -$405M 0.69% 21
2021
Q4
$2.54K Buy
+983,544
New +$366M 0.02% 249
2021
Q2
$912K Buy
+2,510
New +$904K 0.4% 49

Other funds holding NOC

Castleview Partners's NOC Position: Q2 2026 in Review

Castleview Partners reduced its Northrop Grumman (NOC) stake by 0.39% in Q2 2026, selling an estimated $1.15K and leaving 510 shares worth $260K. The position accounts for 0.11% of the portfolio, ranked #182.

Castleview Partners first reported a position in NOC in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.1M in Q1 2022. 342 funds tracked by Wall St. Rank hold NOC as of Q2 2026.

  • Castleview Partners held 510 shares of Northrop Grumman worth $260K as of Q2 2026.
  • Castleview Partners sold 2 Northrop Grumman shares in Q2 2026, an estimated $1.15K.
  • Northrop Grumman made up 0.11% of Castleview Partners's portfolio in Q2 2026, its #182 holding.
  • Castleview Partners first reported a position in Northrop Grumman in Q2 2021 and has held it in 7 quarters since.
  • Castleview Partners's Northrop Grumman position peaked at $1.1M in Q1 2022.
  • 342 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.